Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization
Alzheimer's & Dementia · 2026-05 · 22 (5)
DOI: 10.1002/alz.71469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 20.05.2026. Verfasst von Aadrita Chatterjee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Parkinson Disease, Alzheimer Disease, DNA, Mitochondrial. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Margaret "Peg" McLaughlin and Lydia A. Walker Opportunity Fund, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Mitochondrial DNA copy number (mtDNAcn), a measure of mitochondrial genomes per nucleated cell, has an unclear causal relationship with Alzheimer's disease (AD) and Parkinson's disease (PD). We integrated genetic correlation, polygenic risk scores (PRSs), and Mendelian randomization (MR) to assess whether mtDNAcn influences the risk of AD and PD, and evaluate how study‐specific factors in mtDNAcn genome‐wide association studies (GWASs) distort these causal estimates. METHODS Using GWASs of four mtDNAcn measures, AD, AD/dementia, and PD, we evaluated genetic correlations, generated ancestry‐normalized PRS in the Alzheimer's Disease Genetics Consortium ( N = 27,383), and applied MR methods including latent heritable confounder‐MR (LHC‐MR). RESULTS Across the four mtDNAcn GWASs, only one was consistently associated with AD/dementia and PD, with genetic correlations and PRSs showing negative correlations and MR indicating that higher mtDNAcn reduced AD/dementia and PD risk. DISCUSSION Higher blood‐based mtDNAcn was causally associated with reduced risk of AD/dementia and PD, with limited evidence to suggest a bidirectional effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, Maryland, USA.
- DataTecnica LLC, Washington, District of Columbia, USA.
- Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
- Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
ORCID-Profile: Aadrita Chatterjee, Shea J Andrews
Förderung
- NIA NIH HHS
- Margaret "Peg" McLaughlin and Lydia A. Walker Opportunity Fund
- NINDS NIH HHS
- University of Kansas Alzheimer's Disease Center
- Alzheimer's Association
- NIH-NIA
- NIH HHS
- National Institute of Neurological Disorders and Stroke (NINDS)
Zitieren
APA
Chatterjee, A., Alvarez, B., Sharma, R. U., Jonson, C., Wilkins, H. M., Pa, J., Swerdlow, R. H., Goate, A., Yaffe, K., Andrews, S. J., & Alzheimer's Disease Genetics Consortium and the Alzheimer's Disease Neuroimaging Initiative (2026). Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization. Alzheimer's & Dementia, 22(5). https://doi.org/10.1002/alz.71469
Vancouver
Chatterjee A, Alvarez B, Sharma RU, Jonson C, Wilkins HM, Pa J, et al. Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization. Alzheimer's & Dementia. 2026;22(5). doi:10.1002/alz.71469
BibTeX
@article{Chatterjee2026,
author = {Chatterjee, Aadrita and Alvarez, Brian and Sharma, Rakshya U and Jonson, Caroline and Wilkins, Heather M and Pa, Judy and Swerdlow, Russell H and Goate, Alison and Yaffe, Kristine and Andrews, Shea J and Alzheimer's Disease Genetics Consortium and the Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Genetics Consortium and the Alzheimer's Disease Neuroimaging Initiative},
title = {Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {5},
doi = {10.1002/alz.71469}
}
EUVIMED